Overview

Levosimendan in Congenital Cardiac Surgery

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Many pediatric patients undergoing cardiac surgery under cardiopulmonary bypass for repair of complex congenital malformations, require inotropic support for low cardiac output syndrome. Milrinone through its positive inotropic and vasodilatory effects is widely used for this purpose. The aim of the study is to compare Milrinone with Levosimendan, a novel inotope with calcium-sensitizing properties. We hypothesized that using Levosimendan would result in reduced serum lactate through a higher cardiac index.
Phase:
N/A
Details
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Treatments:
Milrinone
Simendan